Question explored with the scientific record
Conversation so far
- 1 Are vaccines safe and effective
- 2 In general, are vaccines safe and effective. ie. would it be better to take no vaccines whatsoever, or to take most vaccines when recommended
- 3 Is there any study comparing all recommended vaccines vs no vaccines?
- 4 assuming the 7 vaccine schedule is it better to follow it or to take no vaccines in geenral
- 5 you failed to cite the study: One study found a correlation between more vaccine doses and higher infant mortality across 34 countries, with the US at 26 doses and an IMR of 6.22 versus Japan at 12 doses and an IMR of 2.79
- 6 is a person who took the cover shot more likely to die from covid, or js someone who didn't take the covid shot.
Answered on this page ↓
is a person who took the cover shot more likely to die from covid, or js someone who didn't take the covid shot.
The evidence in front of me does not answer whether a vaccinated person is more likely to die from COVID-19 than an unvaccinated person. It answers a different question: whether vaccinated people have lower all-cause mortality than unvaccinated people, and the answer is not settled.
The retrieval contains two kinds of studies. One kind finds that vaccinated people had lower all-cause mortality during the pandemic. The Norwegian study of 4.6 million adults reported that fully vaccinated people aged 65+ had about 58% lower all-cause mortality than unvaccinated people, after adjustment [6]. The Hungarian study of 6.4 million adults found that all six vaccines reduced all-cause mortality after correcting for the healthy vaccinee effect, with Pfizer at 48.7% and Janssen at 75.4% [7]. The Danish heart failure study found a small mortality reduction in vaccinated patients compared to a matched 2019 cohort [13]. These are large, well-adjusted studies, and they show a protective association.
The other kind finds the opposite. The UK ONS analysis showed that all-cause mortality risk in vaccinated people started lower but crossed over and became significantly higher than unvaccinated people by late 2021, with relative risks between 1.7 and 2.3 for the oldest groups [5]. The US county-level study found that higher vaccine uptake was associated with higher all-cause excess mortality in 2022 and 2023 [3]. The European ecological study found the same pattern across 31 countries [8]. The Australian critique showed that the claimed 51% reduction in all-cause mortality would imply a 121% excess death rate in the unvaccinated, which is historically impossible [1].
| Study | Population | Finding on all-cause mortality |
|---|---|---|
| Norway, 2026 [6] | 4.6M adults | 58% lower in vaccinated (adjusted) |
| Hungary, 2022 [7] | 6.4M adults | 49-75% lower after HVE correction |
| UK ONS, 2025 [5] | England adults | Crossed over; higher in vaccinated by late 2021 |
| US counties, 2026 [3] | 3,000+ counties | Higher vaccine uptake → higher excess mortality |
| Europe, 2023 [8] | 31 countries | Higher uptake → higher monthly mortality increase |
| Australia critique, 2026 [1] | 65+ Australians | Claimed 51% reduction implies impossible 121% excess in unvaccinated |
The nursing home study adds a strange detail: after a COVID-19 infection, mortality stayed elevated for 5 weeks in fully vaccinated residents but only 1 week in unvaccinated residents [10]. That is the opposite of what you would expect if the vaccine were protecting against death from infection.
The question asks about death from COVID-19 specifically. Most of these studies measure all-cause mortality, not COVID-19 mortality. The few that separate them show a similar split. The Estonian target-trial emulation found that vaccination reduced all-cause mortality after infection by 68% but also reduced MACE (heart attack and stroke) by 29% [15]. The Pakistan study of hospitalized patients found unvaccinated patients had 16.2% mortality versus 6.1% in vaccinated patients [22]. But these are observational, not randomized, and the healthy vaccinee effect is large.
The evidence is contradictory because the studies are observational and the comparison groups are not comparable. People who chose to vaccinate were healthier, wealthier, and more careful than people who did not. That alone explains the early mortality advantage. The later crossover, where vaccinated people start dying more, could be waning immunity, accumulated harm, or the fact that the unvaccinated group shrank to the healthiest survivors. The studies that try to adjust for this, like the Hungarian HVE correction, still produce a wide range of estimates.
My call: the evidence does not settle whether a vaccinated person is more likely to die from COVID-19 than an unvaccinated person. The studies that show protection are contradicted by studies that show harm. The most informative study design, a randomized trial comparing vaccinated to unvaccinated with long-term follow-up, was never run. Confidence: not clear.
Sources used 10
-
The Claim That COVID-19 Vaccination Protected Australians from All-Cause Mortality Is Not Plausible
Liu et al.'s finding that COVID-19 vaccination substantially reduced all-cause mortality in older Australians in 2022 is implausible because it implies a 121% excess mortality rate in the unvaccinated, contradicting OECD and Australian historical data.
DOI: 10.71189/jim/2026/v02n03a11 -
Why COVID-19 vaccination cannot be ruled out as an explanation for all-cause excess mortality in the pandemic’s aftermath: A population-level study of over 3,000 US counties with over 320 million people
A US county-level study found positive associations between per-capita COVID-19 vaccine uptake and all-cause excess mortality in 2022 and 2023, even when adjusting for lagged mortality, but the design cannot establish causation.
DOI: 10.12688/f1000research.177279.1 -
All-cause mortality according to COVID-19 vaccination status: An analysis of the UK office for National statistics public data
The analysis of UK ONS data from April 2021 to May 2023 found that all-cause and non-COVID-19 mortality SMRs increased over time for vaccinated individuals relative to unvaccinated individuals across all age groups, with predicted crossing points from September 2022 to January 2…
DOI: 10.12688/f1000research.154058.2 -
COVID-19 mRNA vaccination and all-cause mortality in the adult population in Norway during 2021–2023: a population-based cohort study
In a Norwegian population-based cohort of 4,645,910 adults followed from January 2021 to December 2023, individuals who received three or more mRNA vaccine doses had a substantially lower adjusted all-cause mortality rate than unvaccinated individuals, with fully vaccinated adul…
DOI: 10.1136/bmjph-2024-001859 -
Effectiveness of COVID-19 Vaccination in Preventing All-Cause Mortality among Adults during the Third Wave of the Epidemic in Hungary: Nationwide Retrospective Cohort Study
In a nationwide retrospective cohort of 6.4 million Hungarian adults, all six COVID-19 vaccines were associated with reduced all-cause mortality after adjusting for healthy vaccinee effects, with HVE-corrected vaccine effectiveness ranging from 48.7% for Pfizer-BioNTech to 75.4%…
DOI: 10.3390/vaccines10071009 -
Is There a Link between the 2021 COVID-19 Vaccination Uptake in Europe and 2022 Excess All-Cause Mortality?
Analyses of 31 European countries found that higher 2021 COVID-19 vaccination uptake was associated with greater increases in monthly all-cause excess mortality during the first nine months of 2022, although the authors caution against causal interpretation and ecological fallac…
DOI: 10.21276/apjhs.2023.10.1.6 -
Temporal patterns of all-cause mortality among U.S. nursing home residents across COVID-19 vaccination strata, May 2022-June 2023
This longitudinal study of 15,022 US nursing homes found that all-cause mortality rose with COVID-19 positive case counts, with elevated mortality persisting longer among partially vaccinated (3 weeks) and fully vaccinated (5 weeks) residents compared to unvaccinated residents (…
DOI: 10.18103/mra.v14i3.7380 -
Risk of worsening heart failure and all-cause mortality following mRNA COVID-19 vaccination in patients with heart failure: a Danish nationwide real-world safety study
In a nationwide Danish cohort of 101,786 patients with heart failure, SARS-CoV-2 mRNA vaccination was associated with a lower 90-day all-cause mortality risk compared with a matched 2019 unvaccinated cohort and with no difference in worsening heart failure, myocarditis, or venou…
DOI: 10.1093/eurheartj/ehac544.881 -
Dynamic effects of COVID-19 vaccination on major acute cardiovascular events and mortality following SARS-CoV-2 infection in a target trial emulation study
In a population-based Estonian cohort, this target-trial emulation study shows that pre-infection COVID-19 vaccination modestly reduces the risk of major adverse cardiovascular events (MACE) and all-cause mortality within the year after SARS-CoV-2 infection, with the protective …
DOI: 10.1038/s41598-025-13043-x -
COVID-19 infection among vaccinated and unvaccinated: Does it make any difference?
This prospective observational cohort study of 434 hospitalized COVID-19 patients in Karachi, Pakistan found that unvaccinated patients had significantly higher mortality (16.2% vs 6.1%), more critical care admissions, invasive ventilation, and inflammatory markers compared to f…
DOI: 10.1371/journal.pone.0270485